Comparison of analytical parameters of OMP determination at the Ni0.4Cu0.2Zn0.4Fe2O4/CMC/GONs/GCE with other modified electrodesa.
| Electrode | Method | Linear range (μM) | LOD (μM) | Sample | Ref. |
|---|---|---|---|---|---|
| Mercury electrode | DPV | 0.07–300 | 0.02 | Drug, serum | 13 |
| Ni0.5Zn0.5Fe2O4/Gr/GCE | DPV | 0.02–1.4 | 0.13 | Drug, serum | 22 |
| BDDE | DPV | 2.3–14 | 0.91 | Urine, drug | 23 |
| Mercapto-NP-F-CPE | DPV | 0.00025–25.0 | 0.095 | Urine, plasma, water, drug | 83 |
| EPG | SWV | 0.11–100 | 0.019 | Drug, serum | 87 |
| CuO NPs/CPE | ALSV | 0.1–2 | 0.013 | Drug, serum | 91 |
| CPE | SWV | 0.2–50 | 0.025 | Drug | 93 |
| GCE | DPV | 2.9–58 | 0.55 | Drug | 94 |
| S-MWCNTs-Fe3O4/PPDA/GCE | LSV | 0.05–9.0 | 0.015 | Urine, plasma, water, drug | 95 |
| NiOxNPs/GCE | AP | 4.5–120 | 0.4 | Drug | 96 |
| Poly (alizarin)/GCE | DPV | 400–1000 | 0.715 | Drug | 97 |
| DME | DPP | 0.1–1 | 0.7 | Drug, serum | 98 |
| Chit-S@gC3N4/GCE | DPV | 0.6–260 | 0.02 | Drug, serum, urine | 99 |
| Ni0.4Cu0.2Zn0.4Fe2O4/CMC/GONs/GCE | DPV | 0.24–5 5–75 | 0.22 | Drug, serum | This work |
a
LOD: detection of limit; DPV: differential pulse voltammetry; SWV: square wave voltammetry; DPP: differential pulse polarography; AP: amperometry; LSV: linear sweep voltammograms; GCE: glass carbon electrode; CPE: carbon paste electrode; BDDE: boron-doped diamond electrode; DME: dropping mercury electrode; EPG: edge-plane pyrolytic graphite electrode; NiOxNPs: nickel oxide nanoparticles.